Hereditary diffuse gastric cancer in a 34-year-old man with a CDH1 mutation

Patient Info: Anonymized, Male, Under 40 | Stage III

Biomarkers: CDH1 monoallelic deletion of exons 1-2

Under surveillance with the most recent CT showing no active disease and no evidence of disease at the latest follow-up.

PubMed CentralRead more →

Gastric cancer diagnosed after pregnancy-related symptoms and gastric perforation

Patient Info: Anonymized, Female, Under 40 | Stage IV

CT after chemotherapy showed a good response, but her condition later deteriorated with multiple thromboses associated with metastatic disease. She died a few months after diagnosis.

PubMed CentralRead more →

Stage IV gastric cancer with peritoneal metastases responds to combined chemotherapy, surgery and HIPEC

Patient Info: Anonymized, Female, Under 40 | Stage IV

Metastatic Site: peritoneum

At last follow-up in January 2018, she was asymptomatic and examinations showed no evidence of disease.

PubMed CentralRead more →

Stage IV signet-ring gastric cancer with peritoneal metastases treated with chemotherapy, surgery and HIPEC

Patient Info: Anonymized, Female, 50s | Stage IV

Metastatic Site: peritoneum

Developed peritoneal recurrence 3 months after postoperative chemotherapy and was receiving second-line chemotherapy at follow-up.

PubMed CentralRead more →

Stage IV gastric adenocarcinoma progresses despite multiple chemotherapy approaches for peritoneal metastases

Patient Info: Anonymized, Male, Under 40 | Stage IV

Metastatic Site: peritoneum

The cancer progressed during second-line treatment, and he died from tumor-related complications in April 2017, about 16 months after his December 2015 admission.

PubMed CentralRead more →

Stage IV signet-ring gastric cancer with peritoneal metastases treated with chemotherapy, gastrectomy and HIPEC

Patient Info: Anonymized, Male, 50s | Stage IV

Metastatic Site: peritoneum

At follow-up, he had no signs of recurrence.

PubMed CentralRead more →

Robotic gastric cancer surgery in a man with situs inversus totalis and no recurrence at 2.5 years

Patient Info: Anonymized, Male, 50s

Biomarkers: HER2 2+

At 2.5 years after surgery, there was no recurrence.

PubMed CentralRead more →

Stage II gastric adenocarcinoma diagnosed at the same time as Hodgkin lymphoma

Patient Info: Anonymized, Male, 40s | Stage II

Biomarkers: HER2 IHC 0

Routine follow-up was ongoing as of November 2016.

PubMed CentralRead more →

Metastatic gastric cancer returns about 5 years after treatment and causes pulmonary tumor thrombotic microangiopathy

Patient Info: Anonymized, Male, 60s | Stage IV

Metastatic Site: bone marrow; pulmonary microvasculature

He died of respiratory failure from pulmonary tumor thrombotic microangiopathy on hospital day 45, about 5 years after his initial gastric cancer diagnosis.

PubMed CentralRead more →

Gastric Cancer: Do's Survivor Story

Patient Info: Do Lee, Male, 70+

He had shown no evidence of disease since October 2017.

MD AndersonRead more →

Five Years Without Recurrence After Surgery and Gamma Knife for a Cerebellar Metastasis From EGJ Cancer

Patient Info: Anonymized, female, 70+ | Stage IV

Biomarkers: CK7 negative, CK20 positive

Metastatic Site: cerebellum

Five years after removal of the cerebellar metastasis and Gamma Knife radiosurgery, she was asymptomatic with no evidence of recurrence.

PubMed CentralRead more →

Gastric cancer causes severe pulmonary hypertension that improves rapidly with imatinib

Patient Info: Anonymized, Female, 50s | Stage IV

She died from systemic metastatic gastric cancer 7 months after the pulmonary vascular presentation.

PubMed CentralRead more →

Stage III gastric adenocarcinoma later spreads to the gingiva and responds to local treatment

Patient Info: Anonymized, Male, 70+ | Stage IV

Biomarkers: HER2-negative

Metastatic Site: gingiva

The gingival metastasis disappeared after treatment, and the disease remained stable through March 2017.

PubMed CentralRead more →

Gastric cancer surgery in a man recovering from anti-NMDA receptor encephalitis

Patient Info: Anonymized, Male, 50s

At 2 months after surgery, he was symptom-free and had no postoperative complications.

PubMed CentralRead more →

Stage II gastric cancer develops a solitary splenic metastasis one year after surgery

Patient Info: Anonymized, Male, 60s | Stage IV

Metastatic Site: spleen

He remained well with no evidence of recurrence for 18 months after splenectomy, roughly 2.5 years after the original gastrectomy.

PubMed CentralRead more →

Metastatic signet-ring gastric cancer spreads diffusely to the thyroid and skin

Patient Info: Anonymized, Female, 70+ | Stage IV

Metastatic Site: thyroid, skin

She died 1 month after hospitalization after her condition worsened despite supportive care.

PubMed CentralRead more →

Stage IV Signet Ring Gastric Cancer Presenting With DIC and Severe Anemia

Patient Info: Anonymized, male, 70+ | Stage IV

Metastatic Site: bone marrow

His coagulation abnormalities and anemia improved after chemotherapy, and he was discharged in stable condition to continue treatment and oncology follow-up.

PubMed CentralRead more →

Metastatic Gastric Cancer Treatment Complicated by Acute Hypertension During Ramucirumab

Patient Info: Anonymized, male, 60s

After progression on first-line chemotherapy, he had started second-line ramucirumab-based treatment when an acute hypertensive infusion reaction was documented.

PubMed CentralRead more →

Recurrent Gastric Cancer With Peritoneal Spread and Acute Hypertension During Ramucirumab

Patient Info: Anonymized, male, 70+ | Stage IV

Metastatic Site: peritoneum

Treatment was stopped after 2 cycles because of progression, no further cytotoxic treatment was started, and he died at home 19 weeks after the last chemotherapy.

PubMed CentralRead more →

Stage III gastric neuroendocrine carcinoma with signet-ring cells remains recurrence-free 6 years after surgery

Patient Info: Anonymized, Male, 60s | Stage III

Biomarkers: synaptophysin-positive; CD56-positive; Ki-67 23.1%

At 72 months, or 6 years, after surgery, he remained alive without recurrence.

PubMed CentralRead more →

Stage IV HER2-negative gastric adenocarcinoma complicated by acute arterial thrombosis during chemotherapy

Patient Info: Anonymized, Male, 70+ | Stage IV

Biomarkers: HER2-negative

Metastatic Site: peritoneum, retroperitoneal lymph nodes

After recovering from acute arterial thrombosis, he restarted cancer treatment with docetaxel and remained well without further complications at the latest follow-up.

PubMed CentralRead more →

Stage IV gastric cancer with peritoneal metastases controlled for years with intraperitoneal chemotherapy

Patient Info: Anonymized, Female, 60s | Stage IV

Metastatic Site: peritoneum, bone

She had survived 5 years 2 months after diagnosis of peritoneal carcinomatosis, despite later suspected ovarian metastases, confirmed bone metastases and recurrent peritoneal disease.

PubMed CentralRead more →

Gastric Cancer: Ralph's Survivor Story

Patient Info: Ralph Lilja, 50s

Three years after treatment, the patient reported remaining disease-free and having returned to a normal life.

MD AndersonRead more →

Gastric Cancer: Sandra's Patient Story

Patient Info: Sandra Sankar Poukkula, Female, Under 40

Biomarkers: CDH1 mutation

Sandra died from stomach cancer on January 13, 2012, at age 39, just over a year after diagnosis.